Cumulative immunosuppressant exposure is associated with diversified cancer risk among 14 832 patients with systemic lupus erythematosus: a nested case

Cumulative immunosuppressant exposure is associated with diversified cancer risk among 14 832 patients with systemic lupus erythematosus: a nested case–control study

Published:2016-12-30 Issue: Volume: Page:kew457
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Hsu Chung-Yuan,Lin Ming-Shyan,Su Yu-Jih,Cheng Tien-Tsai,Lin Yu-Sheng,Chen Ying-Chou,Chiu Wen-Chan,Chen Tien-Hsing

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Reference42 articles.

1. Mycophenolate mofetil for lupus nephritis: an update

2. Contemporary treatment of systemic lupus erythematosus: an update for clinicians

3. Global Trend of Survival and Damage of Systemic Lupus Erythematosus: Meta-Analysis and Meta-Regression of Observational Studies from the 1950s to 2000s

4. Systemic Lupus Erythematous and Malignancy Risk: A Meta-Analysis

5. The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malignancy in systemic lupus erythematosus: relation to disease characteristics in 92 patients – a single center retrospective study;Rheumatology International;2024-06-08

2. Insomnia disorder and cancer mortality in South Korea: a secondary analysis of musculoskeletal disease cohort;Sleep and Breathing;2024-02-28

3. Case report: Synchronous tumors of the female reproductive tract in systemic lupus erythematosus: report of two cases and review of the literature;Frontiers in Oncology;2024-02-21

4. Evaluating the safety profile of calcineurin inhibitors: cancer risk in patients with systemic lupus erythematosus from the LUNA registry—a historical cohort study;Arthritis Research & Therapy;2024-02-12

5. Real-World Evidence of the Association Between Rheumatoid Arthritis and Lung Cancer;Journal of Thoracic Oncology;2024-02